Protein adducts in the molecular dosimetry of chemical carcinogens

Area of Science:

• Toxicology
• Biochemistry
• Molecular Biology

Background:

• Genotoxic carcinogens bind covalently to both DNA and proteins, forming adducts.
• Protein adducts serve as biomarkers for exposure assessment and understanding carcinogen metabolism.
• The development of molecular dosimetry relies on quantifying these adducts.

Purpose of the Study:

• To review the evolution of molecular dosimetry using protein adducts.
• To explain the principles underlying carcinogen-protein interactions.
• To summarize human population studies and propose future research directions.

Main Methods:

• Reviewing existing literature on protein adduct formation and molecular dosimetry.
• Analyzing studies on the binding specificity of carcinogens to proteins.
• Summarizing epidemiological data from human population studies.

Main Results:

• Protein adducts are valuable for assessing exposure and inter-individual variability in carcinogen processing.
• Carcinogen-protein interactions, particularly with bulky lipophilic agents, often exhibit high specificity.
• Human studies demonstrate the practical application of protein adducts in biomonitoring.

Conclusions:

• Molecular dosimetry based on protein adducts is a robust tool for exposure assessment and risk evaluation.
• Understanding specific carcinogen-protein interactions is crucial for accurate biomonitoring.
• Further research in human populations will refine the use of protein adducts in toxicology.